Biopsy Guidance System Market: Introduction
- Biopsy is a technique to remove a sample of cells or a piece of tissue from body so that it can be examined in a laboratory. It is commonly carried out to diagnose cancer. Biopsy may help identify several other conditions.
- Biopsy guidance systems allow users to target specific areas
- Biopsy guidance system is used in various applications including breast biopsy and brain biopsy
Report Overview @
Key Drivers of Global Biopsy Guidance System Market
- The global biopsy guidance system market is primarily driven by increase in prevalence of chronic diseases such as cancer. According to the World Health Organization, cancer is the second leading cause of death worldwide. Approximately 9.6 million people died due to cancer in 2018 across the globe. About one in six deaths was due to cancer in the same year.
- Increase in awareness about biopsy guidance systems, rise in infrastructure development in the health care sector, impressive reimbursement policies, growth in investment in research & development activities in the health care sector, and increase in number of hospitals and diagnostic centers are expected to drive the demand for biopsy guidance systems during the forecast period.
Stereotactic Guided Biopsy with 2D and 3D Imaging Systems to Expand Significantly
- Based on product type, the global biopsy guidance system market can be divided into stereotactic guided biopsy, ultrasound guided biopsy, and MRI guided biopsy
- The stereotactic guided biopsy segment is anticipated to expand at a rapid pace during the forecast period. The segment’s dominance can be ascribed to new product launches with technological advancement and better efficacy such as 2D/3D imaging systems.
Planning To Lay Down Future Strategy? Request Brochure Of Biopsy Guidance System Market
Hospitals End-user Segment to Offer Lucrative Opportunities
- In terms of end-user, the global biopsy guidance system market can be classified into hospitals, specialty clinics, diagnostic centers, and research and academic institutes
- The hospitals segment is anticipated to account for major share of the global biopsy guidance system market by 2027. The segment’s dominance can be ascribed to the increase in usage of biopsy guidance system in hospitals across the globe due to technological advancements of biopsy guidance systems and increase in the number of patients with chronic diseases (including cardiovascular diseases).
Asia Pacific Biopsy Guidance System Market to Expand Rapidly
- In terms of region, the global biopsy guidance system market can be segregated into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to dominate the global market during the forecast period.
- High prevalence of cancer and introduction of technologically advanced biopsy guidance systems are expected to drive the biopsy guidance system market in North America
- The biopsy guidance system market in Asia Pacific is estimated to expand at a high CAGR during the forecast period owing to the large pool of population with chronic disorders in emerging countries including India and China, and rise in government initiatives
To Obtain All-Inclusive Information On Forecast Analysis Of Biopsy Guidance System Market , Request A Discount
Key Players Operating in Global Market
The global biopsy guidance system market is highly fragmented, with the presence of a large number of domestic players. Key players operating in the global biopsy guidance system market are:
- Becton, Dickinson and Company
- Hologic, Inc.
- Devicor Medical Products, Inc.
- B. Braun Melsungen AG
- ARGON MEDICAL
- Boston Scientific Corporation
- INRAD Inc.
- Cook Medical
- PLANMED OY
More Trending Reports by Transparency Market Research –
Pharmerging Market –
Request For Coronavirus Infection Market Analysis –
No comments:
Post a Comment